OVERVIEW
Mission of Cellivery is to commercialize life-saving therapeutics and cultivate revenue generating partnerships with companies in biotechnology and the pharmaceutical industry around world.
R&D CENTER
Intracellular Protein Therapy with TSDT
Protein transduction exploits the ability of specific basic-,amphipathic- and hydrophobic- cell penetrating peptide (CPP) sequences to enhance the uptake of proteins and other macromolecules by mammalian cells.
PIPELINE
All of Cellivery starts from R&D.
Introducing Cellivery's pipeline.
Advanced Macromolecule Transduction Domain (aMTD)-enabled... more
Suppressor of cytokine signaling 3 (SOCS3) functions as a negative... more
A BBB-Crossing Protein Savior For Damaged Neurons... more
No Carrier! Only Simple Injection For Bone Regeneration!... more
The abnormal control of leptin, an adipocyte-secreted hormone controll... more
Genetically engineered mouse models are useful tools for studying gene... more
Terminally differentiated somatic cells can be reprogrammed to... more
Ataxia is a neurodegenerative disease defined as an impaired voluntary coordination... more
Sepsis is one of the 10 leading causes of death worldwide and widely... more
Single-chain variable fragment (scFv) consists of the smallest functional antigen... more
MEDIA
Cellivery
R&D introduction
Video
R&D is a starting point of drug development and commercialization and a locomotive in realizing continuous growth.